Abstract

Maillard Reactions in Pharmaceutical Formulations and Human Health

Author(s): Newton David W

Issue: Jan/Feb 2011 - Volume 15, Number 1

Page(s): 32-40

Download in electronic PDF format for $75

Abstract

This article reviews pharmaceutical and health implications of the nonenzymatic Maillard reaction, also referred to as browning or N-glycation. The spontaneous Maillard reaction between reducing sugars and amines was first reported by French scientist Louis Maillard in 1912; the Maillard reaction may also occur with other drugs. Hemoglobin A1c and chemically complex colored products that follow initial dextrose and amino acids adducts in parenteral nutrition solutions are the advanced Maillard products most familiar to pharmacists.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2011 Pg. 32-40	Maillard Reactions in Pharmaceutical Formulations and Human Health Author(s): Newton David W
May/Jun 2003 Pg. 170-174	Five Compounds for Treating Diabetes-Related Conditions Author(s): Meece Jerry
Mar/Apr 2016 Pg. 137-141	Formulation and Stability of Solutions Author(s): Akers Michael J
Jan/Feb 2003 Pg. 17-20	Diabetes Mellitus: Pathophysiology and Complications Author(s): Meece Jerry
Mar/Apr 2003 Pg. 114-116	Autoclaves for the Sterilization of Compounded Parenteral Products Author(s): Rahe Hank
Jan/Feb 2004 Pg. 10-14	Women's Oral Health: Is There a Hormonal Link? Author(s): Preckshot John
Jan/Feb 2016 Pg. 41-45	Formulation and Stability of Solutions Author(s): Akers Michael J
Nov/Dec 2020 Pg. 515-518	Development and Evaluation of an Anti-aging Cosmetic Formulation Exploring Antioxidant Potential of Vitis vinifera L. Author(s): Carneiro Jaqueline, Marques Gonçalves Melissa, Vicente Pereira Airton
Sep/Oct 2022 Pg. 385-395	Compounding with Biotechnology Products, Part 1: General Considerations Author(s): Allen Loyd V Jr
Sep/Oct 1998 Pg. 380-381	Standard Operating Procedure for Quality Assessment of Parenteral Nutrition Products Author(s): Allen Loyd V Jr
Mar/Apr 2000 Pg. 103-104	Diabetes Book Reviews Author(s): Reed-Kane Dana
Nov/Dec 2022 Pg. 446-466	Compounding with Biotechnology Products, Part 2: Product-specific Considerations Author(s): Allen Loyd V Jr
Nov/Dec 2020 Pg. 473-478	Intravenous Admixture Preparation Considerations, Part 7: Stability Issues Author(s): Allen Loyd V Jr
Sep/Oct 1998 Pg. 352	Model Parenteral Nutrition Formulation (Veterinary) Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 74-85 View Sample	The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
Nov/Dec 2017 Pg. 481-486	Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations Author(s): Allen Loyd V Jr
Mar/Apr 2000 Pg. 88-90	Complications of Diabetes Author(s): Key David M
Mar/Apr 1999 Pg. 76-79	Men's Health: Practical Solutions to a Profoundly Underrated Health-Care Crisis Author(s): Milner Martin
Jul/Aug 2001 Pg. 246-253	Quality Assurance for Sterile Products Author(s): Kastango Eric S, Douglass Kate
Sep/Oct 1998 Pg. 366	Adult Peripheral Parenteral Nutrition Solution with 4.23% Amino Acids Author(s): Allen Loyd V Jr